IC
WVE icon

Ikarian Capital’s Wave Life Sciences WVE Stock Holding History

Ikarian Capital’s Portfolio WVE Stock Details WVE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-300,000
Closed -$2.4M – 176
2019
Q4 		$2.4M Buy
+300,000
New +$7.35M 0.39% 57

Other funds holding WVE

RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
GP
GSK plc London $602M AUM
MC
Maverick Capital Dallas, Texas $11.3B AUM 76.6% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
6CM
683 Capital Management New York $2.04B AUM 94.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
RAM
Readystate Asset Management Chicago, Illinois $2.93B AUM 18.57% 1-Year Est. Return

Ikarian Capital's WVE Position: Q2 2026 in Review

Ikarian Capital held its Wave Life Sciences (WVE) position steady in Q2 2026 at 85,285 shares worth $496K. The position accounts for 0.05% of the portfolio, ranked #119.

Ikarian Capital first reported a position in WVE in Q3 2021 and has held it in 12 quarters since. The position peaked at $4.87M in Q3 2021. 239 funds tracked by Wall St. Rank hold WVE as of Q2 2026.

  • Ikarian Capital held 85,285 shares of Wave Life Sciences worth $496K as of Q2 2026.
  • Ikarian Capital left its Wave Life Sciences share count unchanged in Q2 2026.
  • Wave Life Sciences made up 0.05% of Ikarian Capital's portfolio in Q2 2026, its #119 holding.
  • Ikarian Capital first reported a position in Wave Life Sciences in Q3 2021 and has held it in 12 quarters since.
  • Ikarian Capital's Wave Life Sciences position peaked at $4.87M in Q3 2021.
  • 239 funds tracked by Wall St. Rank held Wave Life Sciences as of Q2 2026.

Based on Ikarian Capital's 13F filing for Q2 2026, filed 14 Aug 2026.